Single-implant Overdentures Retained by the Novaloc Attachment System
2 other identifiers
interventional
10
1 country
1
Brief Summary
The objective of this explanatory mixed methods study is to compare a novel attachment system (Novaloc) to a traditional alternative (Locator) for single implants in the mandible of edentate elders. The investigators will carry out a randomized cross-over clinical trial comparing Novaloc attachments to Locators for single-implant mandibular overdentures in edentate elders. Participants will be followed for three months with each attachment type; patient-based, clinical and economic outcomes will be gathered. A sample of 26 participants is estimated to be required to detect clinically relevant differences in terms of the primary outcome (patient ratings of general satisfaction). Participants will choose which attachment they wish to keep, then be interviewed about their experiences and preferences with a single implant prosthesis and with the 2 attachments. Data from the quantitative and qualitative assessments will be integrated through a mixed-methods explanatory strategy. A last quantitative assessment will take place after 12 months with preferred attachment; this latter assessment will enable the observation of attachments' long-term wear and maintenance events.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 13, 2017
CompletedFirst Posted
Study publicly available on registry
April 25, 2017
CompletedStudy Start
First participant enrolled
March 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 8, 2021
CompletedSeptember 5, 2021
September 1, 2021
2.6 years
April 13, 2017
September 3, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Denture satisfaction
To be assessed by specific questionnaires
18 months
Secondary Outcomes (9)
Oral health-related quality of life
18 months
Overdenture rotation
18 months
Success/survival rate
18 months
Plaque Index
18 months
Presence of calculus
18 months
- +4 more secondary outcomes
Other Outcomes (1)
Qualitative assessment
6 months
Study Arms (2)
Novaloc, then Locator
EXPERIMENTALParticipants will receive the Novaloc attachment on a single implant inserted in the mandibular midline. This attachment will be used for 3 months and then changed by the Locator attachment. The second attachment will be used for another 3-month period. Participants will keep preferred attachment for further 12 months
Locator, then Novaloc
ACTIVE COMPARATORParticipants will receive the Locator attachment on a single implant inserted in the mandibular midline. This attachment will be used for 3 months and then changed by the Novaloc attachment. The second attachment will be used for another 3-month period. Participants will keep preferred attachment for further 12 months
Interventions
Attachment composed by a polyetheretherketone (PEEK) capsule and carbon-coated abutment. The yellow (medium) retentive component will be used
Traditional cylindrical attachment (Locator system) with pink (medium) retentive components
Eligibility Criteria
You may qualify if:
- Not have had a tooth extraction within the past six months
- Request implant stabilization of a mandibular conventional complete denture
- Have clinically acceptable maxillary and mandibular complete dentures
- Have adequate bone in the anterior mandible for the placement of a single 3.3 mm wide implant in the midline
- Be able to maintain adequate oral hygiene and clean dentures;
- Present no systemic conditions for which minor oral surgery would be counter-indicated
- Have an adequate understanding of written and spoken English or French;
- Be capable of giving written informed consent
You may not qualify if:
- Severe/serious illness that requires frequent hospitalization
- Impaired cognitive function
- Unable to return for evaluations/study recalls
- Have a history of radiation therapy to the orofacial region
- Have specific conditions that may jeopardize the treatment, such as alcoholism or smoking (\>10 cigarettes/day)
- Have acute or chronic symptoms of parafunctional or temporomandibular disorders
- Previous dental implant treatment
- Following radiographic exam, investigators will exclude volunteers with bony pathologic lesions, less than 11 mm of minimum vertical mandibular bone height in the midline or width for planned implants, evident endosseous vascular structures or mandibular ridges with remaining alveolar sockets
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- McGill Universitylead
- ITI International Team for Implantology, Switzerlandcollaborator
- Institut Straumann AGcollaborator
Study Sites (1)
McGill University, Faculty of Dentistry
Montreal, Quebec, H3A1G1, Canada
Related Publications (2)
de Souza RF, Jabbar AA, Jafarpour D, Bedos C, Esfandiari S, Makhoul NM, Dagdeviren D, Abi Nader S, Feine JS. Single-Implant Overdentures Retained by a Novel Attachment: A Mixed Methods Crossover Randomized Clinical Trial. JDR Clin Trans Res. 2024 Jan;9(1):27-41. doi: 10.1177/23800844221124083. Epub 2022 Sep 20.
PMID: 36127832DERIVEDde Souza RF, Bedos C, Esfandiari S, Makhoul NM, Dagdeviren D, Abi Nader S, Jabbar AA, Feine JS. Single-implant overdentures retained by the Novaloc attachment system: study protocol for a mixed-methods randomized cross-over trial. Trials. 2018 Apr 23;19(1):243. doi: 10.1186/s13063-018-2606-7.
PMID: 29685161DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Raphael F de Souza
McGill University, Faculty of Dentistry
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 13, 2017
First Posted
April 25, 2017
Study Start
March 1, 2018
Primary Completion
September 30, 2020
Study Completion
March 8, 2021
Last Updated
September 5, 2021
Record last verified: 2021-09